^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Uveal Melanoma

Related cancers:
1d
Metastasis-related genomic aberrations and evolutionary trajectory in uveal melanoma. (PubMed, Exp Mol Med)
Notably, early 6p gain was frequently exclusive of BAP1 aberrations and associated with a favourable prognosis, suggesting that metastatic potential in UM may be established early during tumorigenesis. Collectively, our findings provide molecular changes contributing to tumorigenesis and metastatic progression in UM and offer potential biomarkers for early detection and prognosis prediction.
Journal
|
BAP1 (BRCA1 Associated Protein 1)
2d
GWAS meta-analysis provides new insights into uveal melanoma risk. (PubMed, Br J Cancer)
This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.
Retrospective data • Journal
|
MTSS1 (MTSS I-BAR Domain Containing 1)
3d
Choroidal melanoma edge recurrence 13 years after I125 plaque brachytherapy. (PubMed, Am J Ophthalmol Case Rep)
This case illustrates a rare late local recurrence of choroidal melanoma with different appearance from the original tumor. It also highlights the diagnostic and prognostic role of transretinal biopsy in confirming the nature of the lesion as a recurrence and the option of proton beam radiation as salvage therapy.
Journal
|
BAP1 (BRCA1 Associated Protein 1) • GNA11 (G Protein Subunit Alpha 11) • SOX10 (SRY-Box 10)
6d
Exceptional response of radiotherapy-naïve cranial meningiomas to dual immune checkpoint blockade in BAP1 tumor predisposition syndrome. (PubMed, Neurooncol Adv)
In sporadic meningiomas, BAP1 alterations are rare but define an aggressive molecular subset with poor outcomes. Here, we describe a patient with BAP1-TPDS and multifocal cranial meningiomas who experienced exceptional radiographic regression of her tumors while receiving dual immune checkpoint blockade for metastatic uveal melanoma.
Journal • Checkpoint inhibition • BRCA Biomarker • PD(L)-1 Biomarker • IO biomarker
|
BAP1 (BRCA1 Associated Protein 1)
8d
GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma. (PubMed, Cancer Res)
Analogous PAX3 positive populations were also identified in mouse and human single-cell transcriptomic datasets. Collectively, these findings establish a critical role for Mitfa-independent melanocyte progenitors in UM pathogenesis.
Journal
|
GNAQ (G Protein Subunit Alpha Q) • FN1 (Fibronectin 1) • PAX3 (Paired Box 3)
|
BRAF V600E
8d
Context-dependent roles of lncRNA JPX in human cancers. (PubMed, Discov Oncol)
JPX should not be regarded as a uniformly oncogenic lncRNA. Its role appears to depend on tumor context, the dominant downstream program, and, in some settings, the status of the JPX-XIST axis. JPX is better viewed as a candidate biomarker and an experimental target than as a clinically validated one.
Review • Journal
|
XIST (X Inactive Specific Transcript)
9d
New P1/2 trial • First-in-human
13d
Glioblastoma treatment patterns and outcomes over 18 years in an Irish cancer centre. (PubMed, Ir J Med Sci)
Despite advances in our understanding of the pathogenesis of glioblastoma, the mOS median overall survival in our real-world patient cohort did not improve over time. The findings emphasise the need for ongoing research efforts to improve outcomes in this lethal disease.
Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
IDH wild-type
13d
Efferocytosis induces proangiogenic function and chromatin remodeling in tumor-associated macrophages. (PubMed, Sci Immunol)
In human uveal melanoma, expression of the effero-score was correlated with poor survival. Therefore, Effero-seq sheds light on the molecular reprogramming induced by efferocytosis in the TME, opening previously unknown avenues for understanding macrophage function and developing targeted treatments.
Journal
|
IFNG (Interferon, gamma)
15d
New P1/2 trial • First-in-human
|
BRAF (B-raf proto-oncogene) • CSPG4 (Chondroitin Sulfate Proteoglycan 4)
|
BRAF mutation • BRAF V600
|
cyclophosphamide • fludarabine IV
16d
Pan-cancer atlas of ITGA6 unveils its multifaceted oncogenic roles and therapeutic potential in uveal melanoma. (PubMed, BMC Cancer)
These findings suggest that ITGA6 may serve as a potential diagnostic and prognostic biomarker in selected cancers and support a tumor-promoting role for ITGA6 in UVM.
Journal • Pan tumor
|
TNFA (Tumor Necrosis Factor-Alpha) • ITGA6 (Integrin, alpha 6)